A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma

Author:

Liu Chia‐Jen12ORCID,Lin Shinn‐Yn34,Yang Ching‐Fen5,Yeh Chiu‐Mei12,Kuan Ai‐Seon6,Wang Hao‐Yuan1,Tsai Chun‐Kuang1,Gau Jyh‐Pyng17,Hsiao Liang‐Tsai17,Chen Po‐Min17,Liu Yao‐Chung17,Hong Ying‐Chung78,Ko Po‐Shen17,Liu Jin‐Hwang1910,Lin Chia‐Hsin137ORCID

Affiliation:

1. Division of Hematology and Oncology Department of Medicine Taipei Veterans General Hospital Taipei Taiwan

2. Institute of Public Health National Yang‐Ming University Taipei Taiwan

3. Department of Radiation Oncology Linkou Chang Gung Memorial Hospital Medical Center Taoyuan City Taiwan

4. Department of Medical Imaging and Radiological Sciences College of Medicine Chang Gung University Taoyuan Taiwan

5. Department of Pathology and Laboratory Medicine Taipei Veterans General Hospital Taipei Taiwan

6. Cancer Epidemiology Unit Nuffield Department of Population Health University of Oxford Oxford UK

7. School of Medicine National Yang‐Ming University Taipei Taiwan

8. Division of Hematology and Oncology Kaohsiung Veterans General Hospital Kaohsiung Taiwan

9. Institute of Biopharmaceutical Sciences National Yang‐Ming University Taipei Taiwan

10. Chong Hin Loon Memorial Cancer and Biotherapy Research Center National Yang‐Ming University Taipei Taiwan

Funder

Ministry of Science and Technology

Taiwan Clinical Oncology Research Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3